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Abstract
Apoptosis is a regulated energy-dependent process for the elimination of unnecessary or
damaged cells during embryonic development, tissue homeostasis and many patholog-
ical conditions. Apoptosis is characterized by specific morphological and biochemical
features in which caspase activation has a pivotal role. During apoptosis, cells undergo
characteristic morphological reorganizations in which the cytoskeleton participates
actively. Traditionally, this cytoskeleton rearrangement has been assigned mainly to
actinomyosin ring contraction, with microtubule and intermediate filaments both
reported to be depolymerized at early stages of apoptosis. However, recent results have
shown that microtubules are reformed during the execution phase of apoptosis forming
an apoptotic microtubule network (AMN). Current hypothesis proposes that AMN is
required to maintain plasma membrane integrity and cell morphology during the exe-
cution phase of apoptosis. AMN disruption provokes apoptotic cell collapse, secondary
necrosis and the subsequent release of toxic molecules which can damage surrounding
cells and promote inflammation. Therefore, AMN formation in physiological or patho-
logical apoptosis is essential for tissue homeostasis.
Keywords: microtubules, actin, intermediate filaments, apoptosis, apoptotic microtu-
bule network
1. Introduction
The term apoptosis refers to the process of programmed cell death characterized by a stereo-
typic sequence of cellular events including cell shrinkage, caspase activation and degradation
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of cell content, blebbing and maintenance of plasma membrane integrity and condensation
and fragmentation of DNA, followed by ordered removal by phagocytes [1]. Apoptosis was
first described in 1972 as a vital biological phenomenon, with both physiological and patho-
logical implications [2]. Apoptosis regulates cell number in tissues serving as a quality control
mechanism in order to eliminate damaged and senescent cells, and it has been proven to be
essential during development of multicellular organisms. In the proliferative environment of
embryonic development, apoptosis helps to shape organs, drives morphogenesis and deletes
structures that won't be required any longer; for instance, the formation of the four-chamber
architecture of the heart is a consequence of this process [3].
Traditionally, the process of apoptosis occurs in three distinct phases: induction, execution and
clearance. The first one comprises all the intrinsic or extrinsic environmental changes that lead
to the activation of the apoptotic cascade. Meanwhile, the execution phase is distinguished by
the activation of a caspase-dependent proteolytic cascade [4]. Caspases are aspartic acid-
specific proteases responsible for cellular components degradation. Some of them, such as
caspase-8 and -9 act as initiators of the apoptotic signalling pathway, while other caspases such
as caspases-3, -6 and -7 operate as executor caspases which actively participate in the degrada-
tion of intracellular proteins [5]. Eventually, the dying cell is engulfed by professional phago-
cytes or by neighbouring cells. This process of apoptotic cell clearance is essential for tissue
turnover and homeostasis [6].
The fate of apoptotic cells in multicellular animals is their prompt elimination by professional
phagocytes. However, cells that perform apoptosis in vitro cultures progress to secondary
necrosis, which implies the loss of membrane integrity and the release of cellular content into
the culturing medium [7]. In vivo, apoptotic cells can also undergo secondary necrosis when
they are not properly eliminated due to massive cell death or impaired phagocytosis [8].
Efficient apoptotic cell removal is driven by the interaction with phagocytes through the
expression of “eat-me” signals, the release of “find-me” signals, engulfment of the dying cell
and its eventual digestion in phagocyte phagolysosomes. This interaction prevents
undesired immune reactions by contributing to the development of an immunomodulatory
environment [9]. On the other hand, secondary necrosis is thought to be pro-inflammatory
and immunogenic, as it causes the release of endogenous damage-associated molecular
patterns (DAMPs) [8]. Among DAMPs are proteolytically processed autoantigens, nucleo-
somes, proteases, calcium-binding protein (calgranulin), high-mobility group box 1 (HMGB-
1) and urate crystals.
2. Cytoskeleton rearrangements during the execution phase of apoptosis
Cell contraction, plasma membrane blebbing, chromatin condensation and DNA fragmenta-
tion are typical hallmarks of the execution phase of apoptosis, which lasts approximately 1 h
[10]. In order to achieve such dramatic morphologic changes, apoptotic cells make profound
cytoskeleton reorganizations. On the other hand, caspase-mediated cytoskeleton proteins
digestion ensures the proper dismantlement of the dying cell [11].
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The eukaryotic cytoskeleton is mainly composed of actin filaments, microtubules and interme-
diate filaments. These three constituents act coordinately to increase tensile strength, allow cell
motility, maintain plasma integrity, participate in cell division, contribute to cell morphology
and provide a network for cellular transport [12]. It is widely accepted that actin cytoskeleton
plays a central role in cell remodelling during the execution phase of apoptosis [13], while
microtubules and intermediate filaments are disorganized at the onset of this phase [10].
However, recent work have demonstrated that microtubules are reorganized at later stages of
apoptosis, giving rise to the formation of the apoptotic microtubule network (AMN) that
contributes to the maintenance of the plasma membrane integrity [14, 15]. All these events are
summarized in Figure 1.
Intermediate filaments are ubiquitous cytoskeletal components of 10 nm of diameter which
provide mechanical strength and allow tissue growing among other functions. According to
amino acid sequence identity, intermediate filaments can be classified into six types. Acidic
keratins belong to type I, whereas basic keratins belong to type II intermediate filaments. They
are typical components of hair and epithelium. Type III includes vimentin, desmin, glial
fibrillary acidic protein and perinephrin. Nuclear lamins A and B, which support the cell
nucleus, are represented by type V. Finally, type VI refers to nestin [16]. Intermediate filaments
connect with other cytoskeletal components via cytolinker proteins of the plakin family,
including desmoplakin, periplakin and plectin [17]. At the onset of the execution phase of
apoptosis, type I keratins are targeted by caspases-3, -7 and -6 at their linker domain, whereas
type II keratins are resistant to caspase-mediated proteolysis. Similarly, type III intermediate
filaments, such as desmin or vimentin, are cleave by caspases. Once cleaved, intermediate
filament subunits accumulate in the cytoplasm forming large aggregates. All these events
contribute to cytoskeleton reorganizations [18]. Furthermore, caspase digestion of K18 (type I)
has been proved to be indispensable for membrane integrity maintenance during apoptosis, as
interference with keratin caspase cleavage shunts hepatocytes towards necrosis [19]. Keratins
are not only caspase substrates but they also seem to regulate the induction phase of apoptosis.
Figure 1. Cytoskeleton rearrangements during the execution phase of apoptosis.
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Thus, it has been shown that deficiencies in keratins 8 and 18 favour tumour necrosis factor
(TNF)/cycloheximide-induced cell death. Keratin 18 sequesters the adaptor molecule TNF
receptor-associated death domain (TRADD) and thus prevents its interaction with the TNF
receptor, regulating negatively apoptosis. In contrast, keratin type II K8 offers protection
against Fas-mediated apoptosis.
With respect to the digestion of nuclear lamins, nuclear breakdown begins with the activation
of caspases. Lamins appear to be specifically targeted by caspases 3 and 6 that become
activated both via the intrinsic and extrinsic pathway of apoptosis [20]. However, little is
known about the exact mechanism by which the cell nucleus dismantles. It has been
established that active caspases are able to proteolyze lamins A and B, leading to lamina
cleavage and chromatin condensation and fragmentation. These alterations contribute to the
collapse of the nucleoskeleton [18].
Microtubules are depolymerized at the same time that intermediate filaments although the
exact molecular mechanism involved is still unknown. Several hypotheses have been postu-
lated to explain this process, which are not mutually exclusive [21]. Microtubules are polar
protofilaments made up of α and β tubulin, which are involved in cell migration, growth,
transport or mitosis [22]. Their dynamics is governed by microtubule-associated proteins
(MAPs), Ran-GTP and proteins that bind to tubulin [22–24]. The cyclin-dependent kinase 1
Cdk1, associated with cyclin B is a key regulatory kinase which controls the entry in mitosis
and regulates microtubule dynamics. In fact, it induces the depolymerization of interphase
microtubules [25]. Cdk1 regulates some microtubule effectors such us MAP4, which reduces
its ability to stabilize microtubules after phosphorylation [26]. In addition, Cdk1 is able to
phosphorylate β-tubulin, thus inhibiting its incorporation to growing protofilaments. As Cdk1
and other Cdks activities have been observed during apoptosis, it has been suggested that they
may act essential regulators in the apoptotic cytoskeleton reorganizations during apoptosis
[27]. On the other hand, some authors have shown that microtubules depolymerization is
associated with activation of the PP2A-like phosphatase, dephosphorylation of the microtu-
bule regulator τ protein and deacetylation of tubulin [28]. This last mechanism can coexist with
the hypothesis of Cdk1 regulation because PP2A downregulates the Cdk1 activator Cdc25
phosphatase [29].
In contrast to the apparent passivity of intermediate filaments and microtubules, the actin
cytoskeleton is highly dynamic, and its remodelling turns out to be essential in the first stages
of apoptosis. Actin filaments function in the generation and maintenance of cell morphology
and polarity, endocytosis, intracellular trafficking, contractility, motility, cell division and apo-
ptosis [30]. Actin is a 42-KDa globular protein (G-actin) which polymerizes to form actin
filaments (F-actin). They adapt to the cell environment through actin-binding proteins (ABPs)
which regulate actin cytoskeleton dynamics. A family of RhoGTPases are in charge of control-
ling ABPs in such a way that actin is organized into highly ordered structures such as stress
fibres, lamellipodia and filopodia in non-apoptotic cells [13].
Once adherent cells have initiated apoptosis, they partially detach from the substrate by losing
their focal adhesion sites. This is achieved by caspase-mediated cleavage of the focal adhesion
kinase pp125, among other proteins [31]. Next, actin is reorganized into an actin-myosin II
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cortical ring with contractile force. Actinomyosin contraction is activated via the Rho/Rho-
kinase (ROCK) signalling pathway which ends up with the phosphorylation of myosin light
chain II (MLC-II) [32]. Rho-kinases are effectors of Rho-GTPase proteins, being RhoA and
RhoC the most well characterized ROCK regulators [33]. Active GTP-bound Rho proteins
activate ROCK by binding to their C-terminal portion of the coiled coil. Then, it induces
actinomyosin contraction through two distinct mechanisms. First, it can increase the phos-
phorylation state of the MLCs by inhibiting the MLC phosphate or by directly phosphorylat-
ing MLC-II [32]. Alternatively, ROCK I but not ROCK II can be cleaved by caspase-3 at a
conserved DETD1113/G sequence and its carboxy-terminal inhibitory domain is consequently
removed [34]. The contractile force generated depends on other ROCK targets, such as the LIM
kinase (a serine/threonine kinase containing LIM and PDZ domains), which phosphorylates
and inactivates the actin stabilizer cofilin [35]. Cortical ring contraction results in the formation
of membrane protrusions known as blebs. Their formation depends on a pressure gradient
between the extracellular medium and the intracellular medium, taking place in areas of
external negative pressure or in places where the plasma membrane is weakened as a conse-
quence of caspase cleavage [11]. Thus, blebbing appears to be also dependent on the activation
of ROCK by active caspases because it can be blocked by Y27632, a ROCK selective inhibitor.
However, C3 toxin-induced inhibition of Rho is unable to block the formation of blebs [36].
Actinomyosin ring contraction is a fast process and coincides with the beginning of the
execution phase. After that, cell content including organelles is packaged into apoptotic bodies
and the actin cytoskeleton is dismantled by caspases [32]. Rho GTPases effectors contribute to
this new cytoskeleton reorganization [11]. The Rho effector protein kinase C-related kinase
(PRK1) is cleaved by caspase-3 generating a constitutively active kinase fragment that is able to
induce actin structures disassembly [37, 38]. Similarly, the Rac effector p21-activated kinase
(PAK2) may promote stress fibres dissolution after caspase cleavage [39]. Likewise, caspase-3
induces gelsolin fragmentation, contributing to the collapse of actin filaments in a calcium-
independent manner [40].
At this time of the execution phase, apoptotic cells lack the main structured elements of
cytoskeleton. It is then, when microtubules reorganize to give rise to the AMN [21]. Its
organization, maintenance and properties will be reviewed in the next sections.
3. Influence of apoptotic cells on tissue remodelling
In tissues, apoptotic cells interact with their neighbouring partners and eventually must be
eliminated. For example, in epithelia apoptotic cells are removed from the tissue by cell
extrusion. Dying cell ejection is usually done apically, although it has been described that cells
also extrude basally during Droshophila development. This coordinated process is necessary
for tissue homeostasis and developmental morphogenesis [41]. In 2001, Rosenblatt et al. pro-
posed a model to describe the sequence of events during epithelia extrusion [42]. They dem-
onstrated that an actinomyosin ring is formed both in the apoptotic and in the neighbouring
non-apoptotic cells. Apoptotic cells were proposed to send an undetermined early signal to the
adjacent epithelial cells to induce the formation of an actinomyosin cable ring as well as the
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activation of small RhoGTPases. Recently, spinsohine-1-phosphate receptor 2 pathway has
been proposed as the mediator between apoptotic and non-apoptotic cells [43]. Contraction of
the cable ring extrudes the now late apoptotic cell out of the epithelium. In other words, during
apoptosis within epithelia, dying cells are able to not only rearrange their cytoskeleton but also
induce actinomyosin reorganizations within adjacent cells. Importantly, apoptotic cell mem-
branes do not permeabilize until cell extrusion is completed [44].
The mechanical force produced during apoptosis is used not only to extrude dying cells from
tissues but also to change the morphology of neighbouring cells to fill the space originally
occupied by the dying cell [45]. This finding suggests that apoptotic forces might be harnessed
throughout cell death-related morphogenesis. Mechanical forces arising from the apoptotic
process had been originally proposed as an “apoptotic force theory” [46] that would
be important during animal development including elimination of interdigital webs, dorsal
closure or leg folding [46, 47]. Therefore, apoptosis should not be seen as a passive carving
process. Instead, it is a generator of mechanical forces and an active player during tissue
remodelling that helps to the correct morphogenesis of embryos and control of tissue
dynamics [47].
4. Apoptotic microtubule network
The reorganization of microtubules during the execution phase of apoptosis has been exam-
ined in a variety of cell lines such as H460, A431, HeLa cells, primary human fibroblasts and
pig LLCPK-1α cells, under several apoptosis inducers such as camptothecin (CPT),
anisomycin, staurosporine, serum withdrawal, UV irradiation and TNF-related apoptosis-
inducing ligand (TRAIL). In addition, apoptotic microtubules have also been observed in cell
fragments and apoptotic bodies [48, 49]. These findings suggest that AMN may play an
important role during the apoptotic process.
Commonly, AMN is arranged beneath plasma membrane, adopting a cortical structure that
gives a “cocoon-like” structure which confines most of the intracellular content of apoptotic
cells. Furthermore, apoptotic microtubules may extend from the body of apoptotic cells as
long and thin spikes, suggesting a key structural role in maintaining apoptotic cell morphol-
ogy and surface extensions (Figure 2). Apoptotic microtubules organization beneath plasma
membrane also suggests that AMN may function as a kind of support to preserve plasma
membrane integrity and/or as a barrier for confining the degradation reactions inside
apoptotic cells.
Apart from plasma membrane protection, another function of apoptotic microtubules has been
associated with the process of apoptotic body formation by helping to sustain the peripheral
localization of chromatin within surface blebs and by facilitating cell fragmentation [48].
To exclude the possibility that AMN could be an artefact of the process of fixation in the
immunofluorescence protocol, apoptotic microtubules formation has been also monitored
in vivo in pig epithelial (LLCPK-1α) expressing GFP-tubulin (Green fluorescent protein-tubulin)
and A431 cells expressing YFP-tubulin (Yellow fluorescent protein-tubulin) by live imaging [48,
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49]. In control interphase cells, microtubules are arranged in long fibres that fill the entire
cytosol, growing from a central microtubule organizing centre (MTOC) corresponding to the
likely position of the centrosome. In cells undergoing apoptosis, this radial network disappears
and is replaced by a cortical arrangement of microtubules corresponding to the AMN observed
by immunofluorescence of fixed cells. Initially, interphase microtubules are depolymerized
while cells rounded up in the early stages of the execution phase of apoptosis. However,
microtubules are soon reorganized beneath plasma membrane with a characteristic cortical
localization.
Under physiological conditions, cytoskeleton proteins support plasma membrane integrity.
Therefore, changes in the cytoskeletal components beneath plasma membrane can increase
membrane permeability. During the execution phase of apoptosis, both the cell cortical actin
network and intermediate filaments which support plasma membrane become depolymerized.
Therefore, apoptotic microtubules are the only remaining cytoskeletal component supporting
plasma membrane and cell shape during apoptosis. The organization of AMN beneath plasma
membrane suggests that tubulin repolymerization in the execution phase of apoptosis may
have a protective role, helping to maintain plasma membrane integrity and thus, delaying the
transition to secondary necrosis. In fact, AMN is present in all genuinely apoptotic cells but is
disrupted in cells undergoing secondary necrosis [49]. Furthermore, AMN disorganization by a
short treatment with colchicine, an inhibitor of tubulin polymerization, increases cell perme-
ability and the release of cell content into the culturing medium. In addition to a purely
supporting role, AMN disorganization by colchicine treatment may also facilitate the access of
Figure 2. Immunofluorescence microscopy image of control and apoptotic cells in the execution phase. Apoptosis was
induced in H460 cells by 10 μM camptothecin treatment for 48 hours. After fixation, control and apoptotic cells were
stained with anti α-tubulin (red), and coumarin-phalloidin to visualize actin filaments (blue). Nuclei were revealed by
Hoechst staining (blue). Arrows, apoptotic cells with AMN. Bar = 15 μM.
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caspases to essential proteins localized in plasma membrane and cellular cortex such as calcium
channels and fodrin (α II-spectrin) whose cleavage could induce ionic imbalance, cellular
collapse and eventually secondary necrosis [50].
5. AMN formation
As mentioned above, formation of AMN is a biphasic process: first, during the early phase of
apoptosis, interphase microtubules rapidly depolymerized, but soon after actin and interme-
diate filaments disassemble they are reorganized in extensive bundles of closely packed new
tubulin polymers. The initial microtubule depolymerization phase correlate with the loss of
centrosomal γ-tubulin, suggesting that the two events may be interconnected [48]. The mech-
anisms involved in centrosome disorganization remain unknown. One hypothesis is that
pericentriolar proteins can be cleaved by active caspases, but to our knowledge, none of these
proteins has been identified as caspase targets [51, 52]. Interestingly, it has been demonstrated
that dynein, a microtubule motor protein, is essential for the centrosomal localization of
pericentrin and γ-tubulin in living cells [53]. Cytoplasmic dynein function is abolished by
caspase cleavage during the execution phase [54]. Therefore, an alternative hypothesis is that
dynein hydrolysis reduces the content of pericentrin and γ-tubulin at the centrosome, thereby
impairing its capacity to nucleate microtubules.
On the other hand, the mechanism of microtubules reassembly in the execution phase remains
uncertain. Although the core centrioles remain essentially intact throughout apoptosis, they
are unlikely to direct the formation of the novel apoptotic microtubule array, because they are
not assembled with a radial pattern, and instead appear randomly throughout the peripheral
cytoplasm. Furthermore, apoptotic microtubules assembly takes place in the absence of γ-
tubulin ring complex, suggesting that AMN formation is produced by another unknown
mechanism [48, 49]. Although they are tightly packed, apoptotic microtubules are dynamic—
assessed by tracking the plus-end protein EB1 by time-lapse imaging [48]—indicating that
their polymerization is regulated.
It has been postulated that active caspases may cleave the C-terminal regulatory regions of
tubulins which increases their ability to polymerize and thus facilitate the formation of apo-
ptotic microtubules [52, 55]. However, AMN reorganization during the execution phase of
apoptosis has been also observed in the presence of caspase inhibitors [49].
In another approach, Jon Lane's group has described that active GTP-bound Ran is necessary
for apoptotic microtubule polymerization, and that RanGTP release into the apoptotic cyto-
plasm triggers microtubule nucleation [56]. They showed that RanGTP-activated spindle
assembly factor, TPX2 (targeting protein for Xklp2), escapes from the nucleus during the
execution phase and associates with apoptotic microtubule bundles [57]. Furthermore, silenc-
ing of TPX2 expression by siRNA impairs apoptotic microtubule polymerization. They pro-
pose that apoptotic microtubule polymerization shares several common characteristics with
mitotic and meiotic spindle assembly, with a particular dependence upon RanGTP and TPX2
[56]. These findings suggest that apoptotic cells utilize the RanGTPase pathway to promote the
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reorganization of apoptotic microtubules. In another study, the examination of apoptotic
microtubules components has showed that in addition to the expected tubulin subunits, they
bind other microtubule-associated proteins (MAP) such as MAP-4. These findings may be
interesting for elucidating the role of MAPs in AMN nucleation. Given previous evidences
associating MAP4 with microtubule nucleation and stabilization [58, 59], this protein may
participate in AMN formation and maintenance during apoptosis.
Although AMN lacks the morphological and functional accuracy of the mitotic/meiotic spindle
apparatus, it nevertheless represents a model of regulated non-centrosomal microtubule poly-
merization, and further accentuates how apoptosis should be viewed as regulated process of
cellular death.
6. Apoptotic microtubules delimit an active-caspase–free area in the
cellular cortex
AMN indeed may work as physical barrier impeding active caspases to access into the cellular
cortex where it can cleave critical proteins involved in plasma membrane integrity [60]. AMN
disorganization in apoptotic cells by colchicine, a microtubule depolymerizing agent, allowed
caspase-mediated cleavage of plasma membrane and cell cortex and proteins such as focal
adhesion kinase (FAK), E-cadherin, α-spectrin, paxilin, Na+/Ca2+ exchanger (NCX), plasma
membrane Ca2+ ATPase-4 (PMCA-4), β4 integrin and Na+/K+ pump subunit β. This caspase-
mediated proteolysis was associated with increase cell permeability, calcium and sodium
overload and bioenergetics failure that eventually led to secondary necrosis [50]. The essential
role of caspase-mediated cleavage of plasma membrane and cortical proteins in plasma mem-
brane permeabilization was demonstrated because the concomitant addition of colchicine and
Z-VAD, a pan-caspase inhibitor, blocked protein cleavage and significantly reduced plasma
membrane permeability and secondary necrosis.
7. Apoptotic cells with AMN enhance phosphatidylserine exposure and
interactions with macrophages
Clearance of apoptotic cells by phagocytes (or efferocytosis) can be divided into four distinct
processes: aggregation of phagocytes near apoptotic cells, recognition of apoptotic cells by cell
surface bridge molecules and receptors, engulfment of apoptotic cells, and degradation of
apoptotic cells within phagocytes [61]. The elimination of apoptotic cells by macrophages
reduces the probability of inflammation by ensuring that apoptotic cells are eliminated before
the release of intracellular contents into de extracellular medium [62, 63]. Apoptotic cells are
recognized by phagocytosis through the externalization of phosphatidylserine in the outer
leaflet of the plasma membrane [64]. Phosphatidylserine translocation is an early event of
apoptosis, occurring while the plasma membrane remains intact and cells exclude membrane-
impermeant dyes [65]. Phosphatidylserine exposure has been reported to be a caspase and
energy-dependent process [66, 67], but its mechanism is not completely understood. It has
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been proposed that a combined effect of activation of a lipid scramblase and downregulation
of a phospholipid translocase activity may contribute to phosphatidylserine exposure [68].
In agreement with a role of apoptotic microtubules for proper phosphatidylserine transloca-
tion, it has been shown that apoptotic cells with AMN show indeed high expression of
phosphatidylserine on the cell surface and increased phagocytosis rate. However, both pro-
cesses were markedly reduced when AMN was depolymerized by colchicine treatment [60].
Interestingly, phosphatidylserine externalization and phagocytosis of apoptotic cells were
restored when AMN was depolymerized in the presence of Z-VAD, suggesting that caspase-
dependent degradation of plasma membrane and cellular cortex proteins impairs proper
phosphatidylserine externalization and apoptotic cell removal by macrophages. These findings
Figure 3. Scheme summarizing the main findings on AMN during the execution phase of apoptosis. (A) Apoptotic cell
interacting with macrophage (B) secondary necrotic cell. PS = Phosphatidylserine.
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corroborate previous observations showing that after AMN disorganization (by nocodazole
treatment) the percentage of macrophages making contacts and engulfing apoptotic cells was
significantly reduced compared to apoptotic cells with AMN [48]. The ability of apoptotic cells
to stimulate their phagocytosis by macrophages before cell lysis is crucial to prevent the
adverse effects (tissue damage and inflammation) associated with secondary necrosis [69]
(Figure 3).
8. Apoptotic microtubules organization and maintenance depend on high
cellular ATP levels and energized mitochondria
Microtubule polymerization is an energy-dependent process because β-tubulin hydrolyzes
GTP during polymerization [70]. Therefore, it has been proposed that AMN formation
depends on the bioenergetic status of apoptotic cells [71].
ATP levels must be kept high in apoptosis to allow all the energy-dependent processes occur-
ring during the execution phase including AMN formation and maintenance. Thus, in vivo
and in vitro experiments have shown that AMN was visualized predominantly in apoptotic
cells with polarized/hyperpolarized mitochondria and, on the contrary, was dismantle in
apoptotic cells with depolarized mitochondria. These observations suggest that AMN depends
on energized mitochondria and high ATP levels [71]. Kinetics examination in pig LLCPK-1α
cells expressing GFP-tubulin also showed that AMN was maintained during the execution
phase of apoptosis until mitochondria depolarization marked the onset of secondary necrosis.
Furthermore, mitochondria depolarization by treatments with uncouplers of mitochondrial
oxidative phosphorylation (FCCP) or mitochondrial inhibitors (antimycin, rotenone and
oligomycin) induced AMN disassembly associated with enhanced plasma membrane perme-
ability. However, inhibition of glycolysis by 2-deoxyglucose treatment had no effect on mito-
chondrial polarization or either AMN organization or plasma membrane permeability. In
contrast, stabilization of apoptotic microtubules by taxol prevented both mitochondrial depo-
larization and plasma membrane permeabilization. AMN stabilization also prevented the
increased plasma membrane permeability when mitochondria were depolarized by rotenone
or FCCP treatment. These results underline the essential role of AMN in plasma membrane
integrity during apoptosis.
9. Zombie cells: Stabilization of apoptotic cells
Taken into account that apoptotic cells maintain the integrity of plasma membrane and cellular
cortex proteins [60], an innovative method aimed to the temporal stabilization and preserva-
tion of apoptotic cells has been developed [72]. This method consists in the treatment of
apoptotic cells with a cocktail of taxol, Zn2+ and coenzyme Q10 (CoQ). This experimental
approach has been reported to prevent secondary necrosis for at least 96 h in cell cultures.
The rationale for using this stabilizing cocktail is (a) taxol, a microtubule stabilizing agent,
prevents AMN depolymerization and the access of active caspases into cellular cortex [73, 74];
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(b) Zn2+, a caspase inhibitor, prevents caspase-dependent cleavage of cellular cortex and
plasma membrane proteins [75–78]; and (c) CoQ, an antioxidant, that protects against oxida-
tive membrane damage which is increased in apoptotic cells [79].
Stabilized apoptotic cells can be considered as dying cells in which the cellular cortex and
plasma membrane are intact or alive. Metaphorically, they can be considered as “living dead”
or “zombie cells”. Stabilized apoptotic cells retain many of the hallmarks characteristic of
apoptotic cells such as cellular cortex and plasma membrane integrity, low intracellular cal-
cium levels, plasma membrane potential, high phosphatidylserine exposure and the ability of
being engulfed by phagocytes.
Recently, interest in apoptosis research has increased remarkably for a number of reasons
including the technological development of cell cultures and the expansion of new therapeutic
strategies. Furthermore, apoptotic cell quantification plays an important role in biomedicine
because it is widely used to evaluate the cytotoxic effects of drugs [80]. However, apoptosis
determination is often affected by the process of cell manipulation (harvesting, cell centrifuga-
tion, cell pipetting…), especially in adherent cell cultures, required for flow cytometry assays.
Very often, these manipulations disrupt plasma membrane permeability and leads apoptotic
cells to secondary necrosis [81]. As a consequence, reliable apoptosis quantifications are par-
ticularly difficult in adherent cell cultures. Stabilization of apoptotic cells before cell harvesting
may allow a more accurate and reliable quantification of the actual number of apoptotic cells
or the correct determination of biochemical parameters such as mitochondrial membrane
potential, intracellular calcium concentration, pH or caspase activity in genuine apoptotic cells.
Currently, apoptotic cells are used for various forms of therapy, especially with the objective of
promoting immunological tolerance in recipient individuals [82]. Therefore, stabilization of
apoptotic cells before their administration to patients may ensure that apoptotic cells will
retain their characteristic features until they are removed by macrophages. The administration
of stabilized apoptotic cells can also be of interest for the delivery of proteins (for protein
replacement therapy) or drugs to recipient macrophages [83].
There are forms of cell death which by their nature impair the correct formation of AMN
(e.g.mitochondrial toxics and cold exposure) [71] and, as a result, apoptotic cells are not
able to maintain plasma membrane integrity. Therefore, apoptotic cell stabilization may
provide a new approach for preventing the adverse effects of early secondary necrosis.
10. Conclusion
Microtubule cytoskeleton is reformed during the execution phase of apoptosis forming an
AMN. AMN is required to maintain plasma membrane integrity and cell morphology during
the execution phase of apoptosis. AMN disruption leads cells to secondary necrosis and the
release of toxic molecules which can damage neighbour cells. Therefore, AMN formation,
preservation or stabilization in apoptosis is essential for tissue homeostasis preventing cell
damage and inflammation.
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